What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A couple of very popular ASX 200 shares have released updates this week and the team at Morgans has been digging into them.

Does the broker rate them as buys this week? Let's see what it is saying after running the rule over their updates:

A man rests his chin in his hands, pondering what is the answer?

Image source: Getty Images

Cochlear Ltd (ASX: COH)

This hearing solutions company's shares came crashing down to earth on Wednesday after making a major downgrade to its FY 2026 guidance.

While some of this downgrade has been driven by geopolitical impacts, the main driver was a surprising decline in demand in developed markets.

Morgans notes that this demonstrates that cochlear implant (CI) demand is more cyclical and macro-sensitive than previously assumed. As a result, it has put a hold rating on its shares with a heavily reduced price target of $107.17 (from $214.93). This compares to its current share price of $92.88. It said:

COH has delivered a material downgrade to FY26 earnings, cutting guidance by c30% at the midpoint. While FX, geopolitics and cost actions contributed, the key takeaway is more fundamental, with CI demand, especially in developed markets, proving to be more cyclical and macro-sensitive than previously assumed.

This challenges the market's long-held view as a structural, volume-driven growth story largely insulated from economic cycles. While we view long-term fundamentals as intact, near-term earnings visibility has deteriorated materially, so we wait for demand stabilisation before re-engaging. We adjust our FY26-28 estimates and lower our target price to A$107.17 HOLD.

Northern Star Resources Ltd (ASX: NST)

Another ASX 200 share that Morgans has been looking at is gold miner Northern Star.

It was pleased with the company's performance, noting that gold sold came in above its revised expectations thanks to improvements following production issues.

In addition, it notes that a $500 million buy back has been announced, that is commencing today.

In response to the update, the broker has retained its buy rating and $30.00 price target on Northern Star's shares. This implies potential upside of 33% for investors. It said:

Gold sold of 381koz at AISC of A$2,709/oz beat our revised expectations, with sequential improvement across all three production centres following ongoing production issues. KCGM Mill Expansion on track for commissioning in early FY27; FY26 guidance has been provided and is above 1,500koz at AISC of A$2,600–2,800/oz. Net cash of A$320m; A$500m on-market buy-back announced, commencing ~23 April. We maintain our BUY rating, price target A$30.00ps (unchanged).

Motley Fool contributor James Mickleboro has positions in Cochlear. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man analysing data on his laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Teen standing in a city street smiling and throwing sparkling gold glitter into the air.
Broker Notes

9 ASX shares just upgraded by the experts

Several ASX 200 gold miners are in the mix.

Read more »

A guys points his fingers down.
Broker Notes

6 ASX shares downgraded by brokers this week

Brokers cut their ratings on Elders, Charter Hall Retail REIT, Sims, and other stocks this week. 

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

Morgans says these ASX shares could return 48% to 95%

The broker is recommending these shares to investors this week.

Read more »

Farmer holding grains in his hands.
Broker Notes

Why this broker thinks GrainCorp shares are a buy after yesterday's fall

This broker is expecting a rebound.

Read more »

Doctor with stethoscope holding a tablet and smiling.
Healthcare Shares

ASX healthcare shares are 39% higher since June. Are you missing out?

Healthcare stocks endured a long slump before the sector pivoted three months ago.

Read more »

Six smiling office colleagues stand in a row and look at the camera.
Broker Notes

9 ASX 200 shares earning strengthened buy ratings this week

Brokers retained a positive view on Santos, Goodman, AMP, Telstra, and other shares this week. 

Read more »

A middle-aged man working from home looks at his mobile phone with a laptop open on the table in front of him.
Broker Notes

Buy, hold, sell: Select Harvests, Seek, SKS Technologies shares

Experts reveal their ratings on 3 ASX shares in the agriculture, communications, and tech segments. 

Read more »